Kiniksa Pharmaceuticals International, plc (KNSA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Kiniksa Pharmaceuticals International, plc, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 51.87x | -32.71x | 87.25x | 5.67x | -5.11x | -6.77x |
| P/B Ratio | 5.39x | 3.22x | 2.80x | 2.62x | 4.36x | 3.50x |
| P/S Ratio | 4.52x | 3.34x | 4.55x | 4.72x | 20.94x | 0.00x |
| Profitability | ||||||
| Gross Margin | 54.6% | 85.6% | 79.1% | 89.6% | 76.4% | 0.0% |
| Operating Margin | 11.4% | -10.8% | -9.3% | 4.4% | -406.4% | 0.0% |
| Net Margin | 8.7% | -10.2% | 5.2% | 83.3% | -409.7% | 0.0% |
| EBITDA Margin | 13.3% | -10.4% | -8.5% | 5.5% | -400.3% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 3.79x | 3.30x | 4.34x | 5.16x | 4.38x | 10.46x |
| Quick Ratio | 3.39x | 3.04x | 3.85x | 4.71x | 4.30x | 10.46x |
| Leverage | ||||||
| Debt/Equity | 0.02x | 0.02x | 0.03x | 0.01x | 0.03x | 0.02x |
YoY = year-over-year change. Source: FMP..